United States· US:75907-094_c77198dd-fd98-ac84-9754-517e77c5c729
Methamphetamine Hydrochloride
A metamfetamine product containing methamphetamine hydrochloride, registered in United States by Dr. Reddy's Laboratories Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHAMPHETAMINE HYDROCHLORIDE
- Manufacturer
- Dr. Reddy's Laboratories Inc
- Country
- United States (US)
- ATC code
- N06BA03
- ATC class
- Metamfetamine
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc117590709401100 TABLET in 1 BOTTLE, PLASTIC (75907-094-01)
- ndc1175907-094-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
176 interactions on record for metamfetamine.
Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metamfetamine · interactions on record
176 records
- 18 severe
- 150 moderate
- 8 info
Most severe, free to view
- PhentermineA08AA01severe
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- MazindolA08AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06BA03
Metamfetamine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd636c8d-e0c2-4a3f-b5a9-fa2b186ddf56 GET /v1/drugs/dd636c8d-e0c2-4a3f-b5a9-fa2b186ddf56?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5",
"substance": "METHAMPHETAMINE HYDROCHLORIDE",
"productndc": "75907-094",
"dosage_form": "TABLET",
"dea_schedule": "CII",
"strength_unit": "mg/1",
"application_number": "ANDA091189",
"marketing_category": "ANDA"
}See everything about metamfetamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.